Inhibrx Biosciences, Inc
Nasdaq INBX · La Jolla, CA
Works in Dermatology · ENT · Genetic & rare · GI & liver · Oncology · Renal & urogenital · Respiratory · Women's health
Inhibrx Biosciences, Inc is a clinical trial sponsor based in La Jolla, CA, listed as Nasdaq INBX. It has 4 active clinical trials with 1,367 planned participants, across 8 therapeutic areas. Since 2021 it has completed 1 trial and stopped 1 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq INBX
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Inhibrx Biosciences, Inc
No warning letter naming Inhibrx Biosciences, Inc is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Inhibrx Biosciences, Inc. The latest inspection ended on 2026-07-02 and was classified VAI (voluntary action indicated). FDA posts a classification after its review, often months after the inspection ended.
Inhibrx Biosciences, Inc is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 1,367 planned participants, in Dermatology, ENT, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 1 trial and stopped 1 early.
Inhibrx Biosciences, Inc is based in La Jolla, CA and is listed as Nasdaq INBX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Inhibrx Biosciences, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-08.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Inhibrx Biosciences, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.